Apathy
58
14
15
25
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.2%
3 terminated out of 58 trials
89.3%
+2.8% vs benchmark
22%
13 trials in Phase 3/4
36%
9 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (58)
Robotic Technologies for APATHy in Dementia: a Randomised Controlled Trial (RAPHAel)
Motivation and Methylphenidate
Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression
The Effects of Apathy on Different Forms of Fatigue
Targeting Apathy With Music in Parkinson's Disease
SENS'REM - SENSoriality and Multi-Sensory Emotional Reminiscences: a Pilot Study
Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
Effects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders
Phase I Trial Evaluating the Pharmacokinetics of Single Ascending Oral Doses of IRL757 in Healthy Elderly Volunteers
Effect of Istradefylline Treatment on Behavioral Measures of Apathy in Parkinson's Disease.
A Randomized Double-Blind Active-Controlled Crossover Trial of Respiratory-Gated Versus Non-Gated Transcutaneous Auricular Vagus Nerve Stimulation for the Treatment of Motor and Non-Motor Symptoms in Parkinson's Disease
A Virtual Life Story Club Intervention to Improve Loneliness and Apathy in Community-Dwelling Older Adults
Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia
Lifestyle Intervention for Improving Insulin Resistance and Concern for Health
Effects of t-DCS and Cognitive Training on Apathy in Elderly With Minor Neurocognitive Impairment
Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment
Respiratory-gated Transcutaneous Auricular Vagus Nerve Stimulation for Improving Apathy in Parkinson's Disease
Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.
Accelerated rTMS vs. Sham for Stroke Apathy
Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics